(INNS)
TARCOCIMAB(INND)
TARKOCIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-453) [VH (HOMO SAPIENS IGHV3- 30*02 (75.8%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT [8.8.16] (26- 33.51-58.97-112)) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1, G1V14 CH2 A1.3, A1.2 (CH1 R120>K (220) (124-221), HINGE 1-15 (222-236), CH2 L1.3>A (240), L1.2>A (241), G1>A (243) (237-346), CH3 E12 (362), M14 (364), L123>C (449) (347-451), CHS (452- 453)) (124-453)], (226-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-16*01 (87.4%) -IGKJ1*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GS-KO), GLYCOFORM ALFA(WHO)
TARCOCIMABUM(INN)